A low-dose triple polypill containing telmisartan, amlodipine, and indapamide led to clinically meaningful improvements in ...

Three years after raising $100 million in series A funds, the Atlas Venture-backed biotech has chosen a lead drug candidate.

Liver fibrosis causes scar tissue to form on the liver, sometimes leading to chronic liver disease. Learn about noninvasive ...

Researchers at the University of Missouri found that diet and exercise can significantly improve liver disease caused by too ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced new research to be presented at The Liver Meeting® 2024, hosted by the ...

A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for ...

A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) — previously known as "non-alcoholic fatty liver disease" — ...

Blocking the enzyme ACMSD can significantly reduce damage caused by metabolic liver disease according to a new study.

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended elafibranor 80mg ...

Experiment suggests liver could be key to restarting neural activities, a discovery that could pave the way for new cardiac ...

Professor Ramou Njie made this disclosure recently during her presentation as part of activities marking liver cancer ...